Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.

Sun W, Zaboli D, Liu Y, Arnaoutakis D, Khan T, Wang H, Koch W, Khan Z, Califano JA.

PLoS One. 2012;7(3):e33642. doi: 10.1371/journal.pone.0033642. Epub 2012 Mar 16.

2.

Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.

Don KR, Ramani P, Ramshankar V, Sherlin HJ, Premkumar P, Natesan A.

Indian J Dent Res. 2014 Nov-Dec;25(6):797-805. doi: 10.4103/0970-9290.152208. Review.

3.

[Epigenetic aspects in carcinomas of the head and neck].

Schmezer P, Plass C.

HNO. 2008 Jun;56(6):594-602. doi: 10.1007/s00106-008-1720-3. Review. German.

4.

Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.

Meng RW, Li YC, Chen X, Huang YX, Shi H, Du DD, Niu X, Lu C, Lu MX.

Sci Rep. 2016 Feb 9;6:20756. doi: 10.1038/srep20756. Review.

5.

Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.

Juodzbalys G, Kasradze D, Cicciù M, Sudeikis A, Banys L, Galindo-Moreno P, Guobis Z.

Cancer Biomark. 2016;17(4):487-502. doi: 10.3233/CBM-160666. Review.

PMID:
27802200
6.

Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.

Lim Y, Sun CX, Tran P, Punyadeera C.

Biomark Med. 2016;10(3):301-13. doi: 10.2217/bmm.16.2. Epub 2016 Feb 17. Review.

PMID:
26888346
7.

Delineating an epigenetic continuum in head and neck cancer.

Worsham MJ, Stephen JK, Chen KM, Havard S, Shah V, Gardner G, Schweitzer VG.

Cancer Lett. 2014 Jan 28;342(2):178-84. doi: 10.1016/j.canlet.2012.02.018. Epub 2012 Mar 1. Review.

8.

Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.

Jia W, Yu T, Cao X, An Q, Yang H.

Medicine (Baltimore). 2016 Oct;95(43):e5040. Review.

9.

Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer.

Michie AM, McCaig AM, Nakagawa R, Vukovic M.

FEBS J. 2010 Jan;277(1):74-80. doi: 10.1111/j.1742-4658.2009.07414.x. Epub 2009 Oct 30. Review.

10.

[The epigenome. Target for innovative therapies in head and neck carcinoma].

Leipold A, Hess J, Zaoui K.

HNO. 2015 Nov;63(11):786-91. doi: 10.1007/s00106-015-0075-9. Review. German.

PMID:
26489412

Supplemental Content

Support Center